1.61
-0.005(-0.31%)
Currency In USD
| Previous Close | 1.62 |
| Open | 1.6 |
| Day High | 1.65 |
| Day Low | 1.57 |
| 52-Week High | 18.72 |
| 52-Week Low | 1.41 |
| Volume | 12,096 |
| Average Volume | 1.52M |
| Market Cap | 4.91M |
| PE | -0.14 |
| EPS | -11.53 |
| Moving Average 50 Days | 1.9 |
| Moving Average 200 Days | 6.72 |
| Change | -0.01 |
If you invested $1000 in Sonnet BioTherapeutics Holdings, Inc. (SONN) 10 years ago, it would be worth $0 as of February 05, 2025 at a share price of $1.61. Whereas If you bought $1000 worth of Sonnet BioTherapeutics Holdings, Inc. (SONN) shares 5 years ago, it would be worth $0.04 as of February 05, 2025 at a share price of $1.61.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent for FHAB® Platform Technology
GlobeNewswire Inc.
Jan 28, 2025 2:05 PM GMT
European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) domain fusion proteins In addition to the U.S. and EU, Sonnet’s global IP coveragenow extends to China, Japan, Russia and New Ze
Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
GlobeNewswire Inc.
Jan 22, 2025 1:35 PM GMT
Live webcast on Wednesday, January 29th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic
Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain Sarcomas
GlobeNewswire Inc.
Jan 21, 2025 2:05 PM GMT
SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters combination evaluation with trabectedin (Yondelis®) with the potential to improve trabectedin’s therapeutic